MedPath

Exercise-based Frailty Intervention in Lung Transplantation (XFIT)

Not Applicable
Not yet recruiting
Conditions
Frailty
Lung Tranplant Candidate
Registration Number
NCT06960421
Lead Sponsor
University of California, San Francisco
Brief Summary

The goal of XFIT study is to measure the safety of an 8-week telehealth-delivered exercise and behavioral training program to treat frailty in lung transplant candidates in their own home. The main questions XFIT aims to answer are:

* Is XFIT safe?

* Is XFIT feasible and acceptable by participants?

* Is XFIT effective in improving frailty and physical function as reflected in patient-reported outcomes.

Participants will:

- Participate in the 8-week XFIT program or enhanced standard of care

Detailed Description

We will randomize 70 patients who reflect the diversity and spectrum of illness seen in the general lung transplant candidate population to either XFIT or enhanced standard of care. An interventionalist with expertise in exercise physiology and remote interventions will deliver 8 weekly sessions using video-conference software in participants' homes. These sessions feature one-on-one exercise training and targeting of behavioral barriers to optimizing physical activity using motivational interviewing principles. Establishing safety is our primary outcome. We will secondarily establish feasibility and acceptability, and explore responsiveness six-minute walk distance, frailty, Patient Reported Outcomes . We anticipate that this first-of-its kind study in solid organ transplantation will establish fundamental safety, feasibility, and accessibility data needed inform larger scale interventions.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Age 18 - 65 years
  • Lung Transplant Candidates
  • Speaks English or Spanish
  • ≤ 8LPM O2 on 6MWT
  • SPPB score ≤ 10
Exclusion Criteria
  • Lives Alone
  • BMI < 18.0 kg/m2
  • Engaged in clinical pulmonary rehabilitation program
  • Severe pHTN (RHC mPAP ≥ 30 mmHg or TTE PASP ≥ 60mmHg or moderately/severely reduced RV systolic function on TTE
  • Deemed unsafe by site PI

Group 2

Inclusion Criteria:

  • Age 18 - 75 years
  • Speaks English or Spanish
  • ≤ 15LPM O2 on 6MWT
  • SPPB score ≤ 10

Exclusion Criteria:

  • Lives Alone
  • BMI < 18.0 kg/m2
  • Engaged in clinical pulmonary rehabilitation program
  • Severely reduced RV systolic function on TTE
  • Deemed unsafe by site PI

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Death8 weeks
Major cardiovascular event8 weeks
> 2 unplanned hospitalizations8 weeks
Secondary Outcome Measures
NameTimeMethod
Desaturation8 weeks
Coughing8 weeks
Presyncope8 weeks

Trial Locations

Locations (4)

University of California,San Francisco

🇺🇸

San Francisco, California, United States

Columbia University

🇺🇸

New York, New York, United States

University of North Carolina

🇺🇸

Chapel Hill, North Carolina, United States

University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath